GSK/Dr. Reddy’s Form Deal To Co-Promote Branded Generics In Emerging Markets
This article was originally published in The Pink Sheet Daily
Executive Summary
Strategic alliance expands GSK’s reach in emerging markets, just after deal in May with South African generics drug maker Aspen.
You may also be interested in...
Abbott Ups Emerging Markets Ante With Zydus Deal, Established Products Unit
The acquisition of Solvay's pharmaceutical unit, completed in February, gave Abbott a substantial branded generics business and strengthened its international presence. Now the company is looking to build on those assets with an enhanced emerging market strategy
Abbott Ups Emerging Markets Ante With Zydus Deal, Established Products Unit
Abbott licenses 24 drugs from Zydos and forms an Established Products Division focused on emerging markets.
Abbott Ups Emerging Markets Ante With Zydus Deal, Established Products Unit
Abbott licenses 24 drugs from Zydos and forms an Established Products Division focused on emerging markets.